Kovacs, Krisztina <br/><br/>
PARP Inhibitor Protects Against Chronic Hypoxia/Reoxygenation-Induced Retinal Injury by Regulation of MAPKs, HIF1α, Nrf2, and NFκB.  [electronic resource] 

 -  Investigative ophthalmology & visual science  04 2019 
 - 1478-1490 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1552-5783 
<br/><br/><label>Standard No.: </label>10.1167/iovs.18-25936  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Chronic Disease<br/>Cytokines--metabolism<br/>Disease Models, Animal<br/>Fluorescent Antibody Technique, Indirect<br/>Hypoxia--complications<br/>Hypoxia-Inducible Factor 1, alpha Subunit--metabolism<br/>Immunoblotting<br/>Intercellular Signaling Peptides and Proteins--metabolism<br/>Male<br/>NF-E2-Related Factor 2--metabolism<br/>NF-kappa B--metabolism<br/>Oxidative Stress<br/>Oxygen--toxicity<br/>Phosphorylation<br/>Phthalazines--therapeutic use<br/>Piperazines--therapeutic use<br/>Poly (ADP-Ribose) Polymerase-1--antagonists & inhibitors<br/>Poly(ADP-ribose) Polymerase Inhibitors--therapeutic use<br/>Rats<br/>Rats, Wistar<br/>Reactive Oxygen Species--metabolism<br/>Reperfusion Injury--metabolism<br/>Retinal Diseases--metabolism<br/>p38 Mitogen-Activated Protein Kinases--metabolism